In melanoma, the increased expression of RUNX2 endows tumor cells with metastatic capability, possibly by re-activating the MAPK and PI3K/AKT pathways [177] Sp1 is a transcription factor whose nuclear translocation is contingent upon its phosphorylation. Here, PIK3CA is linked to neoplasm.